Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and thrombin.

J W Fenton1, D V Brezniak, F A Ofosu

  • 1Pharmaceutical Research Institute at Albany, Albany College of Pharmacy, Albany, NY, USA.

Current Drug Targets. Cardiovascular & Haematological Disorders
|April 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden-onset unilateral ptosis induced by pituitary Macroadenoma, with false-positive jolly and neostigmine tests.

Journal of biological regulators and homeostatic agents·2018
Same author

The Significant Role of c-Abl Kinase in Barrier Altering Agonists-mediated Cytoskeletal Biomechanics.

Scientific reports·2018
Same author

Imatinib Alters Agonists-mediated Cytoskeletal Biomechanics in Lung Endothelium.

Scientific reports·2017
Same author

Differential elastic responses to barrier-altering agonists in two types of human lung endothelium.

Biochemical and biophysical research communications·2016
Same author

Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi survey.

BJOG : an international journal of obstetrics and gynaecology·2016
Same author

Physical activity intensity and type 2 diabetes risk in overweight youth: a randomized trial.

International journal of obesity (2005)·2015
Same journal

Non-invasive atherosclerosis imaging: use to assess response to novel or combination lipid therapies.

Current drug targets. Cardiovascular & haematological disorders·2006
Same journal

Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reduction.

Current drug targets. Cardiovascular & haematological disorders·2006
Same journal

Matrix metalloproteinases: a potential therapeutic target in atherosclerosis.

Current drug targets. Cardiovascular & haematological disorders·2006
Same journal

Liver x receptors: potential novel targets in cardiovascular diseases.

Current drug targets. Cardiovascular & haematological disorders·2006
Same journal

Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis.

Current drug targets. Cardiovascular & haematological disorders·2006
Same journal

Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.

Current drug targets. Cardiovascular & haematological disorders·2006
See all related articles

Statins and dietary isoprenoids inhibit thrombin generation by downregulating the Rho pathway, independent of cholesterol synthesis. This mechanism may explain statins' pleiotropic effects on cellular signaling.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • L-Mevalonic acid is a precursor to isoprenoids like farnesyl and geranylgeranyl pyrophosphates, which anchor G-proteins to membranes.
  • Geranylgeranyl-proteins, such as Rho GTP binding proteins, regulate signaling pathways and are implicated in thrombin generation.

Purpose of the Study:

  • To investigate the role of statins and dietary isoprenoids in inhibiting thrombin generation, independent of cholesterol synthesis.
  • To explore the mechanism involving the Rho pathway and its impact on cellular signaling.

Main Methods:

  • Utilized PAR-1 activating peptide (SSFLRNP) to assess platelet stimulation with cerivastatin and atorvastatin.
  • Measured prothrombin fragments F1+2 in type 2 diabetic plasma treated with simvastatin.

Related Experiment Videos

Main Results:

  • Cerivastatin and atorvastatin mitigated platelet stimulation in a time- and dose-dependent manner, supporting a statin-mediated Rho pathway.
  • Simvastatin reduced prothrombin fragments F1+2, indicating statins downregulate thrombin generation in diabetics.
  • Statins and dietary isoprenoids inhibit tissue factor-dependent thrombin generation.

Conclusions:

  • Statins and dietary isoprenoids act as inhibitors of thrombin generation via the Rho pathway, independent of cholesterol reduction.
  • The downregulation of thrombin-mediated events at the cellular level may account for the pleiotropic effects of statins.